期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

T细胞非霍奇金淋巴瘤的药物治疗

Drug therapy of T-ceU non- Hodgkin Iymphoma
原文传递
导出
摘要 近年来出现了多种针对T细胞非霍奇金淋巴瘤（T-NHL）的新的治疗药物，如核苷类似物、新型BCR／ABL酪氨酸激酶抑制剂、左旋门冬酰胺酶、蛋白酶体抑制剂、细胞因子类药物及单克隆抗体等，在治疗中都显示出一定的疗效。 In recent years, a variety of new therapeutic drugs have shown a certain effect on T-cell non - Hodgkin lymphoma （ T- NHL）, such as nucleoside analogues, BCR / ABL tyrosine kinase inhibitor, L - asparaginase,protease inhibitor,cytokines,and monoclonal antibodies.
作者 刘伟(综述) 余英豪(综述)
机构地区 福建医科大学福总临床医学院南京军区福州总医院病理科
出处 《国际肿瘤学杂志》 CAS 2010年第4期308-311,共4页 Journal of International Oncology
基金 南京军区医学科学技术研究“十一五”计划项目（07Z034）
关键词 淋巴瘤 非霍奇金 T淋巴细胞 药物疗法 Lymphoma, non- Hodgkin T- lymphocytes Drug therapy
分类号 R733.1 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Jaffe ES.The 2008 WHO classification of lymphomas:implications for clinical practice and translational research.Hematology Am Soc Hematol Educ Program,2009,14(3):523-53l.
  • 2Marchi E,Alinari L,Tani M,et al.Gemcitabine as frontline treatment for cutaneous T-cell lymphoma:phase Ⅱ study of 32 patients.Cancer,2005,104(11):2437-2441.
  • 3Kim JG,Sohn SK,Chae YS,et al.CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T-cell lymphomas.Cancer Chemother Pharmacol,2006,58(l):35-39.
  • 4DeAngelo DJ.Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.Hematol Oncol Clin North Am,2009,23(5):1121 -1135.
  • 5Berg SL,Blaney SM,Devidas M,et al.Phase Ⅱ study of nelarabine (compound 506U78) in children and young adults with refractory Tcell malignancies:a report from the Children's Oncology Group.J Clin Oncol,2005,23(15):3376-3382.
  • 6Wassmann B,Pfeifer H,Goekbuget N,et al.Alternating versus concurrent schedules of imatinib and chemtherapy as front-line therapy for Philadephia-positive acute lymphoblastic leukemia (Ph+ ALL).Blood,2006,108(5):1469-1477.
  • 7Talpz M,Shah NP,Kantarjian H,et al.Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.N Engl J Med,2006,354(24):2531-2541.
  • 8Yong W,Zheng W,Zhu J,et al.Midline NK/T-cell lymphoma nasaltype:treatment outcome,the effect of L-asparaginase based regimen,and prognostic factors.Hematol Oncol,2006,24(1):28-32.
  • 9Yamaguchi M,Suzuki R,Kwong YL,et al.Phase I study of dexamethasone,methotrexate,ifosfamide,L-asparaginase,and etoposide (SMILE) chemotherapy for advanced-stage,relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.Cancer Sci,2008,99(5):1016-1020.
  • 10Cheson BD.Novel therapies for peripheral T-cell non-Hodgkin's lymphomas.Curr Opin Hematol,2009,16(4):299-305.
国际肿瘤学杂志
2010年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部